Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
46,200
-1,300 (-2.74%)
Last updated: Jun 26, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Polymer and Drug Delivery System Technologies Products
9.53B
Log In
Log In
Log In
Other
8.40M
Log In
Log In
Log In
Other Growth
-15.98%
Log In
Log In
Log In
Endoscopic Hemostatic Agent
-
Log In
Log In
Log In
Endoscopic Hemostatic Agent Growth
-
Log In
Log In
Log In
Vascular Embolic Microspheres
-
Log In
Log In
Log In
Vascular Embolic Microspheres Growth
-
Log In
Log In
Log In
Vascular Embolic Microspheres-F
-
Log In
Log In
Log In
Vascular Embolic Microspheres-F Growth
-
Log In
Log In
Log In
Gastrointestinal Stents
-
Log In
Log In
Log In
Gastrointestinal Stents Growth
-
Log In
Log In
Log In
Other
8.40M
Log In
Log In
Log In
Other Growth
-15.98%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Other
68.96M
Log In
Log In
Log In
Europe
4.40B
Log In
Log In
Log In
United States
4.39B
Log In
Log In
Log In
South Korea
676.12M
Log In
Log In
Log In
South Korea Growth
-86.15%
Log In
Log In
Log In
Other
68.96M
Log In
Log In
Log In